Desktop wide screen and notebook header

  • Limited 10% discount on monthly subscriptions @ subscribe to The middle Road | The middle Road supports Melinda Gates backed Techstars Future of Longevity Accelerator

Tablets header

  • Limited 10% discount on monthly subscriptions @ subscribe to The middle Road | The middle Road supports Melinda Gates backed Techstars Future of Longevity Accelerator

Mobile header

  • Limited 10% discount on monthly subscriptions @ subscribe to The middle Road | The middle Road supports Melinda Gates backed Techstars Future of Longevity Accelerator

Episode 18: Dr. Chandrakant Lahariya Thought Leader — Public Policy & Health Systems Expert

Viruses stand at 1031 compared to the human population at 8 billion i.e.  8*109, a telling figure of how dangerous our ecosystem can become.

In this episode, Nishant Malhotra has an in-depth conversation with Dr. Chandrakant Lahariya, one of the foremost healthcare experts and thought leaders in Asia about the COVID-19 pandemic. Our conversation covers various aspects of the pandemic and a must for anyone interested in understanding the efforts of global actors within the healthcare ecosystem in fighting the COVID-19 pandemic. Learn more about mRNA vaccines, difference between Mucormycosis and Black Fungus, Remdesivir divergent results, overview of the randomized double-blind controlled trial, steroids as a COVID-19 response, Delta variant and much more.

Dr. Chandrakant is a leading epidemiologist, public policy and health systems expert based in India. He is also the co-author of the book Till We Win, an extremely insightful, informative, and fluid book on COVID-19 and India’s fight against the COVID-19 pandemic. Dr. Gagandeep Kang and Dr. Randeep Guleria are the other co-authors of the book. Dr. Chandrakant Lahariya is the youngest fellow ever to be elected to the Indian Public Health Association (IPHA), that works with leading healthcare experts to design healthcare policies and programs at the state and national level in India. He is presently focusing on universal and primary healthcare in India.

 

Apple | Spotify 

 

                             Hello, Dr. Chandrakant delighted to have you for a thought-provoking conversation.

 

You dont have access to this material.kindly subscribe to premium.Click here to Purchase membership